We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Novavax Inc | NASDAQ:NVAX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.1999 | -4.20% | 4.5601 | 4.56 | 4.58 | 4.94 | 4.475 | 4.94 | 5,255,100 | 21:24:30 |
1. Name and Address of Reporting Person * Glenn Gregory M | 2. Issuer Name and Ticker or Trading Symbol NOVAVAX INC [ NVAX ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) President, R&D |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 8/18/2020 | M | 3200 | A | $50.0 | 5039 | D | |||
Common Stock | 8/18/2020 | M | 7500 | A | $25.60 | 12539 | D | |||
Common Stock | 8/18/2020 | M | 4405 | A | $36.60 | 16944 | D | |||
Common Stock | 8/18/2020 | M | 8200 | A | $27.0 | 25144 | D | |||
Common Stock | 8/18/2020 | M | 2733 | A | $27 | 27877 | D | |||
Common Stock | 8/18/2020 | M | 16658 | A | $27.60 | 44535 | D | |||
Common Stock | 8/18/2020 | M | 13225 | A | $46 | 57760 | D | |||
Common Stock | 8/18/2020 | S | 6288 | D | $143.94 (1) | 51472 | D | |||
Common Stock | 8/18/2020 | S | 31957 | D | $145 (2) | 19515 | D | |||
Common Stock | 8/18/2020 | S | 17151 | D | $146 (3) | 2364 | D | |||
Common Stock | 8/18/2020 | S | 525 | D | $146.58 (4) | 1839 | D | |||
Common Stock | 8/18/2020 | G | V | 1528 | D | $0 | 311 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option (Right to Buy) | $50 | 8/18/2020 | M | 3200 | (5) | 3/10/2021 | Common Stock | 3200 | $0.0 | 0.0 | D | ||||
Stock Option (Right to Buy) | $25.6 | 8/18/2020 | M | 7500 | (6) | 3/1/2022 | Common Stock | 7500 | $0.0 | 0.0 | D | ||||
Stock Option (Right to Buy) | $36.6 | 8/18/2020 | M | 4405 | (7) | 3/2/2023 | Common Stock | 4405 | $0.0 | 0.0 | D | ||||
Stock Option (Right to Buy) | $27.0 | 8/18/2020 | M | 8200 | (8) | 11/14/2026 | Common Stock | 8200 | $0.0 | 550 | D | ||||
Stock Option (Right to Buy) | $27.0 | 8/18/2020 | M | 2733 | (9) | 11/14/2026 | Common Stock | 2733 | $0.0 | 6017 | D | ||||
Stock Option (Right to Buy) | $27.6 | 8/18/2020 | M | 16658 | (10) | 12/15/2027 | Common Stock | 16658 | $0.0 | 8341 | D | ||||
Stock Option (Right to Buy) | $46 | 8/18/2020 | M | 13225 | (11) | 12/13/2028 | Common Stock | 13225 | $0 | 18524 | D |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Glenn Gregory M C/O NOVAVAX, INC. 21 FIRSTFIELD ROAD GAITHERSBURG, MD 20878 | President, R&D |
Signatures | ||
/s/ John A. Herrmann III, Attorney-in-Fact | 8/20/2020 | |
**Signature of Reporting Person | Date |
1 Year Novavax Chart |
1 Month Novavax Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions